• Home
  • About Us
  • Advisory board
  • Neurology
    • Alzheimer’s Disease
    • Epilepsy
    • Headache/Migraine
    • Movement Disorders
    • Multiple Sclerosis
    • Neuro-Oncology
    • Neuroradiology
    • Neurosurgery
    • Pain
    • Stroke
    • All Articles
    • All Videos
  • Psychiatry
    • Addiction
    • ADHD
    • Anxiety
    • Bipolar Disorder
    • Depression
    • Obesity
    • OCD
    • Psychosis
    • Schizophrenia
    • Sleep Disorders
    • All Articles
    • All Videos
  • CNS Journal
  • CME
  • Podcasts
    • All Podcasts
    • Navigating the PD universe
    • Reflections on Parkinson’s Disease
    • Parkinson Weekly
Adjunctive Lithium Reduces Use of Newer Antipsychotics in Bipolar

Adjunctive Lithium Reduces Use of Newer Antipsychotics in Bipolar

by Ket Patel | Mar 6, 2012 | All Articles For Psychiatry, Bipolar Disorder

In a 6-month study, the use of adjunctive moderately dosed lithium to optimized treatment in patients with bipolar disorder was well tolerated yet did not lead to improved outcomes or decreased suicidality. However, use of adjunctive lithium resulted in a significant...
Adjunctive Lithium Reduces Use of Newer Antipsychotics in Bipolar

Framingham Score Flags MI Risk After Stroke

by Ket Patel | Mar 5, 2012 | All Articles For Neurology, Stroke

An elevated Framingham Risk Score identified recent ischemic stroke patients at high risk for a myocardial infarction or vascular death over the next 2 years, in a retrospective analysis of data from more than 2,500 stroke survivors without documented coronary heart...
Adjunctive Lithium Reduces Use of Newer Antipsychotics in Bipolar

FDA Approves First Generic Form of Escitalopram

by Ket Patel | Mar 5, 2012 | All Articles For Psychiatry, Anxiety, Depression

The first generic formulation of the selective serotonin reuptake inhibitor escitalopram has been approved by the Food and Drug Administration, the agency announced on March 14. In a statement, the FDA said that generic escitalopram – in 5-mg, 10-mg, and 20-mg doses –...
Adjunctive Lithium Reduces Use of Newer Antipsychotics in Bipolar

Sleep-Disordered Breathing in Early Childhood Linked With Behavioral Outcomes

by Ket Patel | Mar 4, 2012 | All Articles For Psychiatry, Sleep Disorders

Sleep-disordered breathing in infancy and early childhood increases the likelihood of problematic behavior in later childhood, findings from a large, population-based, longitudinal study suggest. The findings, based on an analysis of data from more than 11,000...
Adjunctive Lithium Reduces Use of Newer Antipsychotics in Bipolar

‘Drip and Ship’ Proves Safe for Stroke

by Ket Patel | Mar 4, 2012 | All Articles For Neurology, Stroke

“Drip and ship” is a safe way to manage patients with acute ischemic stroke, according to results from two separate studies. A review of 145 ischemic stroke patients who began receiving an intravenous infusion of tissue plasminogen activator (TPA) at a...
Page 160 of 168««...102030...159160161...»»

Follow Us

  • Follow
  • Follow
  • Follow
  • Follow

Newsletter

Keep up to date with our latest
articles and journals

Subscribe

Oruen is the leading CNS medical publication and audio-visual platform committed to improving international communication and medical education for physicians with clinical interests in CNS medicine.

Navigation
  • Home
  • About Us
  • Advisory Board
  • CNS Journal
  • CME
  • Contact Us
Contact Oruen

Name: Dr. James Coe  (MD, PhD)

Editor

E-mail: Editor@oruen.com

  • Follow
  • Follow
  • Follow
  • Follow
  • Follow

Copyright © 2026. Oruen LTD. All Rights Reserved. | Terms & Conditions | Privacy Policy | Sitemap

We use cookies to ensure that we give you the best experience on our website, please read our Privacy Policy before using this website.